Paul Renhowe

Paul Renhowe is an experienced pharmaceutical professional with a focus on drug discovery, particularly in the field of medicinal chemistry. Paul has held leadership positions in various companies, including Matchpoint Therapeutics, where they currently serve as the Vice President and Head of Drug Discovery. Prior to that, they held the same role at Theonys before transitioning to Matchpoint Therapeutics.

Paul's previous experience includes roles at Cyclerion, Ironwood Pharmaceuticals, Novartis, and Chiron Corporation. At Cyclerion, they held senior director positions in both Discovery Sciences and Discovery Chemistry, where they led teams in Medicinal Chemistry and managed various departments. At Ironwood Pharmaceuticals, they served as Senior Director of Medicinal & Computational Chemistry, overseeing the development of clinical candidates.

Before that, Paul worked at Novartis as the Director of Medicinal Chemistry, leading and mentoring project teams in the field of oncology. Paul was also a key member of the Novartis Global Discovery Chemistry Leadership Team.

At Chiron Corporation, Paul held roles as an Associate Director and Principal Scientist in Medicinal Chemistry, where they led discovery programs and played a key role in the development of kinase inhibitors for cancer treatment.

Throughout their career, Paul has demonstrated strong leadership skills, strategic planning, and a track record of delivering successful clinical candidates.

Paul Renhowe completed their Bachelor of Science degree in Chemistry from North Dakota State University between 1986 and 1990. Following this, they pursued a PhD in Organic Chemistry at UC Irvine from 1990 to 1995.